Status:
COMPLETED
Genetic Polymorphysm of Cholesterol 24 S Hydroxylase in Patients With Glaucoma and AMD
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Glaucoma
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The aim of this study is to assess the implicitement of the cholesterol 24 S hydroxylase gene and the 24 S hydroxycholesterol in glaucoma and in age related macular degeneration.
Eligibility Criteria
Inclusion
- Patient with Glaucoma
- Patient with AMD
- Healthy patient
Exclusion
- All patients who use any treatment in order to maintain in normal value their blood cholesterol
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2011
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT00629044
Start Date
November 1 2007
End Date
January 1 2011
Last Update
March 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmology Unit CHU Dijon
Dijon, Burgundy, France, 21000